June has arrived and whether you’re looking for fun in the sun or seeking cultural activities around the city, we’ve got recommendations on how to fully enjoy your summer in San Francisco.
Guest:
James Salazar, staff writer, San Francisco Examiner
We'll also talk with experts about the benefits of Ozempic and other GLP-1 receptor agonists beyond the treatment of type 2 diabetes and weight loss.
Guests:
Dr. Diana Thiara, medical director, UCSF Weight Management program
Sara Reardon, freelance science journalist
And finally, we’ll hear about a collection of 20th century political art, located right here in the Bay Area!
Guest:
Tom Areton, co-founder and director, Museum of International Propaganda
Resources:
San Francisco Examiner: Your comprehensive guide to spending a summer in San Francisco
Scientific American: First Weight-Loss Drug Gets Approval for Heart Disease. Here’s What We Know
Scientific American: Could New Weight-Loss Drugs like Ozempic Treat Addiction?
New York Times: Ozempic Cuts Risk of Chronic Kidney Disease Complications, Study Finds
Time: Is Ozempic the New Anti-Inflammatory Wonder Drug?
CNN Health: ‘Ozempic babies’: Reports of surprise pregnancies raise new questions about weight loss drugs
Fred Hutchinson Cancer Center: The new weight-loss drugs and cancer
Host: Grace Won
Producers: Kendra Klang, Gillian Emblad
